Pancreatic Cancer Research

ResearcherUniversity Hospitals of ClevelandActive in the last 2 years

Lan Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-1291-534X; OpenAlex author ID A5102934810; NIH RePORTER profile ID 8704097. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 3)
Trials
0
Grants
2
Labs led
2
Collaborators
11
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: 2 papers · 2015: none · 2016: 1 paper · 2017: 1 paper · 2018: 1 grant · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 grant

Papers 6

  1. Targeting CRABP-II overcomes pancreatic cancer drug resistance by reversing lipid raft cholesterol accumulation and AKT survival signaling. Last author DOI 10.1186/s13046-022-02261-0↗
  2. CRABP-II enhances pancreatic cancer cell migration and invasion by stabilizing interleukin 8 expression. Last author DOI 10.18632/oncotarget.14194↗
  3. Cellular Prion Protein Mediates Pancreatic Cancer Cell Survival and Invasion through Association with and Enhanced Signaling of Notch1. Last author DOI 10.1016/j.ajpath.2016.07.010↗
  4. CRABP-II is a highly sensitive and specific diagnostic molecular marker for pancreatic ductal adenocarcinoma in distinguishing from benign pancreatic condition… Co-author DOI 10.1016/j.humpath.2014.01.014↗
  5. Utilization of CDX2 expression in diagnosing pancreatic ductal adenocarcinoma and predicting prognosis. Co-author DOI 10.1371/journal.pone.0086853↗
  6. Association of prion protein expression with pancreatic adenocarcinoma survival in the SEER residual tissue repository. Co-author DOI 10.3233/cbm-2012-0256↗

Grants 2

  1. Mechanisms of JAG1-mediated immune suppression in the pancreatic cancer microenvironment R01CA294584↗
  2. Role of CRABP-II in pancreatic cancer metastasis R03CA201738↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shuiliang Yu · 4 shared papers, 1 shared grant, 2014–2022 · strength 0.68
  2. Wei Xin · 6 shared papers, 2011–2022 · strength 0.42
  3. Ming Li · 2 shared papers, 2017–2022 · strength 0.24
  4. Lei Wang · 1 shared paper, 2022 · strength 0.16
  5. Yiwei Wang · 2 shared papers, 2016–2017 · strength 0.12
  6. Mark W. Jackson · 2 shared papers, 2016–2017 · strength 0.12
  7. Wenbin Xiao · 2 shared papers, 2014 · strength 0.11
  8. Man‐Sun Sy · 2 shared papers, 2011–2016 · strength 0.07
  9. Marc T Goodman · 1 shared paper, 2011 · strength 0.03
  10. Charles F. Lynch · 1 shared paper, 2011 · strength 0.03
  11. Stephen M. Hewitt · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.